The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers

Natalie I Vokes,1,2 Jianjun Zhang1,2 1Department of Thoracic and Head and Neck Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Natalie I Vokes; Jianjun Zhang Ema...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vokes NI, Zhang J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/7b8d0bd9bb5d4aa68d1792fd8d759974
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7b8d0bd9bb5d4aa68d1792fd8d759974
record_format dspace
spelling oai:doaj.org-article:7b8d0bd9bb5d4aa68d1792fd8d7599742021-12-02T19:17:36ZThe Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers1179-2728https://doaj.org/article/7b8d0bd9bb5d4aa68d1792fd8d7599742021-12-01T00:00:00Zhttps://www.dovepress.com/the-role-of-whole-exome-sequencing-in-distinguishing-primary-and-secon-peer-reviewed-fulltext-article-LCTThttps://doaj.org/toc/1179-2728Natalie I Vokes,1,2 Jianjun Zhang1,2 1Department of Thoracic and Head and Neck Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Natalie I Vokes; Jianjun Zhang Email nvokes@mdanderson.org; jzhang20@mdanderson.orgAbstract: Non-small cell lung cancer (NSCLC) that presents with multiple lung tumors (MLTs) poses a challenge to accurate staging and prognosis. MLTs that arise as clonally related secondary metastases from a common primary are higher stage and often require adjuvant chemotherapy or may in fact be incurable stage IV lesions. Conversely, MLTs that represent distinct primaries have a better prognosis and may be overtreated if inappropriately classified as related secondaries. Historically, pathologic and radiographic criteria were used to distinguish between primary and secondary MLTs; however, the advent of genomic profiling has demonstrated limitations to these historic classification systems. In this review, we discuss the use of molecular profiling to distinguish between primary and secondary lung cancers, with a focus on the insights gleaned from whole exome sequencing (WES) analyses. While WES is not yet feasible in routine clinical practice, WES studies have helped elucidate the clonal relationship between primary and secondary lung cancers and provide important context for the application of targeted sequencing panel-based analyses.Keywords: genomics, non-small cell lung cancer, metastasisVokes NIZhang JDove Medical Pressarticlegenomicsnon-small cell lung cancermetastasisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENLung Cancer: Targets and Therapy, Vol Volume 12, Pp 139-149 (2021)
institution DOAJ
collection DOAJ
language EN
topic genomics
non-small cell lung cancer
metastasis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle genomics
non-small cell lung cancer
metastasis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Vokes NI
Zhang J
The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers
description Natalie I Vokes,1,2 Jianjun Zhang1,2 1Department of Thoracic and Head and Neck Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Natalie I Vokes; Jianjun Zhang Email nvokes@mdanderson.org; jzhang20@mdanderson.orgAbstract: Non-small cell lung cancer (NSCLC) that presents with multiple lung tumors (MLTs) poses a challenge to accurate staging and prognosis. MLTs that arise as clonally related secondary metastases from a common primary are higher stage and often require adjuvant chemotherapy or may in fact be incurable stage IV lesions. Conversely, MLTs that represent distinct primaries have a better prognosis and may be overtreated if inappropriately classified as related secondaries. Historically, pathologic and radiographic criteria were used to distinguish between primary and secondary MLTs; however, the advent of genomic profiling has demonstrated limitations to these historic classification systems. In this review, we discuss the use of molecular profiling to distinguish between primary and secondary lung cancers, with a focus on the insights gleaned from whole exome sequencing (WES) analyses. While WES is not yet feasible in routine clinical practice, WES studies have helped elucidate the clonal relationship between primary and secondary lung cancers and provide important context for the application of targeted sequencing panel-based analyses.Keywords: genomics, non-small cell lung cancer, metastasis
format article
author Vokes NI
Zhang J
author_facet Vokes NI
Zhang J
author_sort Vokes NI
title The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers
title_short The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers
title_full The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers
title_fullStr The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers
title_full_unstemmed The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers
title_sort role of whole exome sequencing in distinguishing primary and secondary lung cancers
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/7b8d0bd9bb5d4aa68d1792fd8d759974
work_keys_str_mv AT vokesni theroleofwholeexomesequencingindistinguishingprimaryandsecondarylungcancers
AT zhangj theroleofwholeexomesequencingindistinguishingprimaryandsecondarylungcancers
AT vokesni roleofwholeexomesequencingindistinguishingprimaryandsecondarylungcancers
AT zhangj roleofwholeexomesequencingindistinguishingprimaryandsecondarylungcancers
_version_ 1718376860042133504